ERISA’s Hidden Cost: Why US Health Insurers Can Deny Claims with Legal Immunity
A 52-year-old federal law designed to protect employee pensions has become a legal shield that bars millions of US patients…
Editor's Top Picks
Decades-Old Understanding of Common Stroke Challenged by New Research on Blood Vessel Damage
Researchers have discovered that a common stroke type long attributed to atherosclerotic plaque may actually stem from enlargement and damage…
Submit Your Paper to GMJ
HIV infection triggers CD4+ T cells to transform into CD8+ cells, Science study reveals
Groundbreaking research shows HIV-1 can convert CD4+ helper T cells into CD8+ cells while preserving immune memory, potentially explaining persistent…
AI Shows Limited Advantage Over Traditional Methods in Flu Vaccine Design
New research in Nature Medicine shows AI algorithms achieve only modest improvements over traditional expert methods in selecting flu vaccine…
New Imaging Technique Reveals Hidden Brain Tumors Missed by Standard MRI
Stanford researchers developed enhanced contrast MRI that detects hidden brain tumors missed by standard imaging in 23% of patients. The…
China’s biotech reforms accelerate drug development and patient access
China's integration of national reforms with institutional redesign has accelerated drug development and improved patient access to medicines. Global momentum…
Dexcom Reports Theft of Defective G7 Glucose Sensors Designated for Destruction
Dexcom has notified the FDA of theft involving defective G7 glucose sensors that were designated as manufacturing scrap and intended…
FDA Issues Safety Correction for KayserBett IDA Pediatric Care Beds Due to Entrapment Risk
FDA issues safety correction for KayserBett IDA pediatric care beds due to child entrapment risks when hand controls are not…
Nigeria’s NAFDAC Launches Digital Platform to Combat Counterfeit Medicines
Nigeria's NAFDAC launches enhanced Med Safety App enabling healthcare workers and citizens to report suspected counterfeit medicines and adverse drug…
New Oral AML Treatment Shows Promise for Older Patients in FDA Trial
New oral drug combination for older AML patients shows effectiveness comparable to IV therapy, potentially eliminating monthly hospital visits. ASCERTAIN…